- Home
- LVS vs EW Comparison
LVS vs EW Comparison
Compare LVS & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVS
- EW
- Stock Information
- Founded
- LVS 1988
- EW 1958
- Country
- LVS United States
- EW United States
- Employees
- LVS N/A
- EW N/A
- Industry
- LVS Hotels/Resorts
- EW Industrial Specialties
- Sector
- LVS Consumer Discretionary
- EW Health Care
- Exchange
- LVS Nasdaq
- EW Nasdaq
- Market Cap
- LVS 38.3B
- EW 42.5B
- IPO Year
- LVS 2004
- EW 2000
- Fundamental
- Price
- LVS $52.26
- EW $74.78
- Analyst Decision
- LVS Buy
- EW Buy
- Analyst Count
- LVS 14
- EW 21
- Target Price
- LVS $58.69
- EW $79.40
- AVG Volume (30 Days)
- LVS 4.8M
- EW 5.6M
- Earning Date
- LVS 01-22-2025
- EW 02-04-2025
- Dividend Yield
- LVS 1.53%
- EW N/A
- EPS Growth
- LVS 133.34
- EW 193.69
- EPS
- LVS 2.02
- EW 6.89
- Revenue
- LVS $11,317,000,000.00
- EW $6,314,900,000.00
- Revenue This Year
- LVS $10.21
- EW N/A
- Revenue Next Year
- LVS $9.76
- EW $0.91
- P/E Ratio
- LVS $25.88
- EW $28.85
- Revenue Growth
- LVS 31.99
- EW 24.02
- 52 Week Low
- LVS $36.62
- EW $58.93
- 52 Week High
- LVS $56.61
- EW $96.12
- Technical
- Relative Strength Index (RSI)
- LVS 49.52
- EW 62.35
- Support Level
- LVS $50.91
- EW $72.29
- Resistance Level
- LVS $53.93
- EW $74.58
- Average True Range (ATR)
- LVS 1.34
- EW 1.93
- MACD
- LVS -0.36
- EW 0.06
- Stochastic Oscillator
- LVS 23.68
- EW 91.36
About LVS Las Vegas Sands Corp.
Las Vegas Sands is the world's largest operator of fully integrated resorts, featuring casino, hotel, entertainment, food and beverage, retail, and convention center operations. The company owns the Venetian Macao, Sands Macao, Londoner Macao, Four Seasons Hotel Macao, and Parisian Macao, as well as the Marina Bay Sands resort in Singapore. We expect Sands to open a fourth tower in Singapore toward the end of 2028. Its Venetian and Palazzo Las Vegas assets in the U.S. were sold to Apollo and VICI in 2022. With the sale of its Vegas assets, the company generates all its EBITDA from Asia, with its casino operations generating the majority of sales.
About EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US.